5 big analyst AI moves: Apple lifted to Buy, AI chip bets reassessed
Investing.com -- Synthomer PLC (LON:SYNT) on Thursday reported that demand remains weak across its markets, leading the company to lower its full-year outlook.
The chemical company now expects its EBITDA for fiscal year 2025 to be "similar" to the £143 million reported in fiscal year 2024, revising previous guidance that had projected "some progress." The company also indicated it would be "broadly FCF neutral" for the year.
In its trading update, Synthomer described third-quarter 2025 trading as "resilient" with ongoing soft demand being offset by self-help measures. The company’s current share price stands at 56.90p, with analysts maintaining a price target of 76.00p, representing 34% potential upside.
The company’s Advanced Surfaces (AS) division continued to regain market share and enhance margins, supported by investments in APO capacity that are expected to benefit next year even without a demand recovery.
In the Health & Protection (H&P) segment, volumes for medical gloves remained subdued. The company noted that despite improved customer sentiment, it has not yet seen the benefits of customer tariffs reflected in its order book.
The Coatings & Construction Solutions (CCS) division experienced mixed results across end markets, with improving construction and stable consumer demand offset by slower coatings demand, particularly in the United States, and weaker oil and gas sector performance.
Looking ahead to next year, the company indicated there are no clear signs of a market recovery, though some positive factors exist. Industry observers anticipate potential progress on divestments in the near term, which could be beneficial ahead of planned refinancing, though timing remains uncertain.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.